BIOCON
Back to Balance Sheet
|
BIOCON Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹12,404 Cr | ₹16,493 Cr | ₹15,120 Cr | ₹20,742 Cr | ₹6,803 Cr |
What is the latest Total Non-Current Liabilities ratio of BIOCON ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2026 | ₹12,404 Cr |
| Mar2025 | ₹16,493 Cr |
| Mar2024 | ₹15,120 Cr |
| Mar2023 | ₹20,742 Cr |
| Mar2022 | ₹6,803 Cr |
How is Total Non-Current Liabilities of BIOCON Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹12,404 Cr | -24.79 | |
| Mar2025 | ₹16,493 Cr | 9.08 | |
| Mar2024 | ₹15,120 Cr | -27.11 | |
| Mar2023 | ₹20,742 Cr | 204.91 | |
| Mar2022 | ₹6,803 Cr | - | |
Compare Total Non-Current Liabilities of peers of BIOCON
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BIOCON | ₹63,973.9 Cr | -2.2% | -8.7% | 8.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹451,339.0 Cr | -2.7% | -3.7% | 20.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹254,068.0 Cr | 3.7% | 15.7% | 51% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,767.0 Cr | -0.8% | 1% | 36.2% | Stock Analytics | |
| CIPLA | ₹111,804.0 Cr | -2.1% | -5.2% | -11.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,113.4 Cr | -0.8% | -0.5% | -9.3% | Stock Analytics | |
BIOCON Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BIOCON | -2.2% |
-8.7% |
8.9% |
| SENSEX | -1.8% |
-3.7% |
-5.7% |
You may also like the below Video Courses